Kristine Slam, MD, FACP, Central Ohio Surgical Associates, addresses the importance of involving patients in decisions regarding their goals for treatment, emphasizing that this involvement is critical to uncover what they value, as well as their short- and long-term goals for treatment.
"Part of the discussion we have with patients is, what are their values? It's really bringing the patient front and center and asking them about their short- and long-term goals, and their fears, because each patient chooses different surgery and different therapy based on that," noted Kristine Slam, MD, Central Ohio Surgical Associates, in an interview from our September 14 Institute for Value-Based Medicine® event, held in partnership with the Zangmeister Cancer Center of Columbus, Ohio.
Transcript
What roles do patient engagement and shared decision-making play in value-based care for breast cancer?
So patient decision-making and patient involvement in decision-making is critical. What I have found over my years is patients have different values and expectations. One of the things that comes to forefront with this is the application of breast radiation for, again, elderly lower-risk women. For years, we told patients a lumpectomy goes with radiation like peanut butter and jelly—you can't do one without the other. We have 2 very-long-term studies that clearly prove in low-risk elderly women, radiation does not make a patient live longer. It lowers the recurrence rate in the breast, but never eliminates it.
So part of the discussion we have with patients is, what are their values? Is their value and is their goal for their therapy living longer? Because if so, radiation is not going to help that. Is their goal to reduce their breast cancer risk as much as possible? If so, radiation might help. It's really bringing the patient front and center and asking them what their short-term and long term goals are, what their fears are, because each patient chooses different surgery and different therapy based on that.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AA Unlikely to Cause Anxiety, Depression but May Be Affected by Mental Illness
May 7th 2024A Mendelian randomization study using genetic analysis found that alopecia areata (AA) increases the risk of anxiety and depression, but not the other way around, providing unique evidence for a causal link while adding to existing evidence.
Read More